Randomized controlled study comparing the Taperloc complete versus the Taperloc complete Microplasty.
- Conditions
- hip artrosiship wear10023213
- Registration Number
- NL-OMON46938
- Lead Sponsor
- Zimmer Biomet Nederland BV
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 50
These are standard indications for usage of the Taperloc Complete and Taperloc Microplasty stem. ;Subjects with one of the following indications:
Non-inflammatory degenerative joint disease including osteoarthritis, avascular necrosis and rheumatoid arthritis.
Correction of functional deformity. ;Additional inclusion criteria include:
Male or female
> 18 and * 70 years of age
Subjects willing to return for follow-up evaluations.
Subjects able to read and understand Dutch language.
Active Infection (or within 6 weeks after infection)
Sepsis
Osteomyelitis;Uncooperative patient or patient with neurologic disorders who are incapable of following directions
diagnosed Osteoporosis or Osteomalacia
Metabolic disorders which may impair bone formation
Distant foci of infections which may spread to the implant site
Rapid joint destruction, marked bone loss or bone resorption apparent on roentgenogram
Vascular insufficiency, muscular atrophy or neuromuscular disease.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>Primary study endpoint is migration at two year measured with RSA</p><br>
- Secondary Outcome Measures
Name Time Method <p>Secondary study parameters/endpoints are malalignment, incorrect sizing,<br /><br>subsidence and intraoperative fractures, early survival of the hip prosthesis<br /><br>at 2 year and Clinical performance based on the clinician based outcome (HHS<br /><br>and radiological evaluation) and the patient based outcomes (HOOS, EQ5D, Oxford<br /><br>Hip score, Forgotten Hip).<br /><br>One site will perform migration analysis with RSA. Migration at two year will<br /><br>be the primary endpoint for this sub-group.</p><br>